Company intelligence / Profile preview

Labinderb

Ròtova, Valencia/València, Spainlabinderb.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Labinderb operates as a contract manufacturer of personalized food supplements and nutraceuticals for human and veterinary use. The company holds ISO 22000 and GMP-Codex certifications. It has participated as a sponsor in at least one clinical trial evaluating the effect of a probiotic dietary supplement.[7] No pharmaceutical drug development or advanced clinical pipeline was identified.

Therapeutic areas: GastroenterologyOther
Modalities: Small molecule (for dietary supplements/nutraceuticals)Protein (if applicable in nutraceutical blends)Herbal extract-based products
Industry: Food & Nutrition

Partnerships

Not publicly disclosed; likely works with various brands/private label clients as CDMO.

Beyond the preview

Go deeper on Labinderb.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Labinderb.

Explore the full profile